A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

The Man Who Wants to Live Forever introduced many viewers to the Minicircle company, and here's what the organization ...

Researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine ...

Swiss drugmaker Novartis said on Monday its gene therapy helped improve motor function in children with a rare muscle ...

Cell Therapy and Gene Therapy CDMO Market is Segmented by Type (Cell Therapy, Gene Therapy), by Application (Clinical Stage Projects, Commercialization ...

On 30 December 2024, Novartis reported that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) reached ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

Sangamo said it plans to explore all options to commercialise the asset, including seeking a potential new collaboration partner.

GT-0002X is under clinical development by Gene Therapy Research Institution and currently in Phase II for Parkinson's Disease.

Gene Synthesis IndustryThe global gene synthesis industry is set for significant growth, with its valuation projected to rise from USD 779.4 million in 2023 to over USD 4.5 billion by 2033. This ...

Montpellier, France Monday, December 30, 2024, 13:00 Hrs [IST] ...